Montelukast Prescribing at SPRING HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
259
Total Quantity
9,450
NHS Cost
£503
vs National Avg
-62.2%
SPRING HOUSE SURGERY prescribed 259 items of Montelukast over the last 12 months at a cost of £503 to the NHS. This is 62.2% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
26
Jun 2026
19
Jun 2026
24
Jun 2026
16
Jun 2026
22
Jun 2026
17
Jun 2026
19
Jun 2026
22
Jun 2026
26
Jun 2026
22
Jun 2026
21
Jun 2026
25
Prescribing Details
| Total Items | 259 |
|---|---|
| Total Quantity | 9,450 |
| Total NHS Cost | £503 |
| Presentations | 3 different forms |
| vs National Average | -62.2% |
Montelukast Prescribing Comparison
| This practice | 259 items |
|---|---|
| National average per practice | 685 items |
| Difference | -62.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.